DCM
BDSX icon

Driehaus Capital Management’s Biodesix BDSX Stock Holding History

Driehaus Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,250
Closed -$330K – 391
2021
Q2 		$330K Sell
1,250
-1,075
-46% -$338K ﹤0.01% 397
2021
Q1 		$944K Buy
+2,325
New +$1.04M 0.01% 359

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Driehaus Capital Management's BDSX Position: Q3 2021 in Review

Driehaus Capital Management sold out of Biodesix (BDSX) in Q3 2021, closing a stake of 1,250 shares — an estimated $330K sold.

Driehaus Capital Management first reported a position in BDSX in Q1 2021 and held it in 2 quarters. The position peaked at $944K in Q1 2021. 42 funds tracked by Wall St. Rank hold BDSX as of Q3 2021.

  • Driehaus Capital Management reported no remaining Biodesix position as of Q3 2021 after selling out during the quarter.
  • Driehaus Capital Management sold 1,250 Biodesix shares in Q3 2021, an estimated $330K.
  • Driehaus Capital Management first reported a position in Biodesix in Q1 2021 and held it in 2 quarters.
  • Driehaus Capital Management's Biodesix position peaked at $944K in Q1 2021.
  • 42 funds tracked by Wall St. Rank held Biodesix as of Q3 2021.

Based on Driehaus Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.